SLXNW
Biomotion Sciences WarrantNASDAQ
Key Statistics
Market Cap
—
P/E Ratio
—
EPS
—
Beta
-0.26
52W High
$0.10
52W Low
$0.01
50-Day MA
$0.00
200-Day MA
$0.00
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Biomotion Sciences Warrant
Biomotion Sciences Warrant (ticker: SLXNW) is associated with an innovative biotechnology firm focused on delivering advanced therapeutic solutions for significant unmet medical needs. The company's commitment to robust research and development places it strategically in the biopharmaceutical sector, poised for considerable growth. As Biomotion Sciences navigates clinical trials and forges strategic partnerships, it amplifies its potential for substantial investment returns within the dynamic healthcare market, supported by a broadening product pipeline.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-12.72M |
| Operating Margin | 0.00% |
| Return on Equity | -897.00% |
| Return on Assets | -123.30% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.86 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 159.80% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 0 |
| Float | 414,620 |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Historical Volatility
HV 10-Day
—
HV 20-Day
—
HV 30-Day
—
HV 60-Day
—
HV Rank
—
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on SLXNW and any ticker you trade — then tracks every position and per-strategy win rate.
Data last updated: 7/29/2026